Institutional Ownership
Ani Pharmaceuticals Inc
CUSIP 00182C103COMANIPQ1 2026
Institutional Holders
271
13F filers
Shares Held
21.95M
Aggregate institutional
Institutional Value
$1.66B
Q1 2026
Net New Holders
-8
35 new · 43 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions35
Increased110
Decreased83
Sold out43
Institutional Holders
271 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 2.75M | $211.28M | +85.8K | Added |
| 2 | Soleus Capital Management, L.P. | 820.2K | $63.08M | +334.0K | Added |
| 3 | State Street Corp | 771.6K | $59.34M | +44.4K | Added |
| 4 | Tang Capital Management LLC | 707.5K | $54.41M | +226.1K | Added |
| 5 | Goldentree Asset Management LP | 668.0K | $51.30M | +668.0K | New |
| 6 | Deep Track Capital, LP | 600.0K | $46.14M | +122.3K | Added |
| 7 | Millennium Management LLC | 592.0K | $45.53M | +52.3K | Added |
| 8 | Arrowstreet Capital, Limited Partnership | 564.4K | $43.40M | +91.2K | Added |
| 9 | Dimensional Fund Advisors LP | 531.2K | $40.84M | +43.5K | Added |
| 10 | Ubs Group AG | 497.7K | $38.27M | +346.9K | Added |
261 more institutional holders on Premium
See every fund holding Ani Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders